CISBIO – Curium Pharma
Jacobsen Ingénierie a réalisé une étude de conformité et de vieillissement des équipements de ventilation nucléaire HVAC des bâtiments 549 et 555.
ventilation HVAC, Etudes de conformité réglementaire, rapport de sûreté
1051
portfolio_page-template-default,single,single-portfolio_page,postid-1051,bridge-core-3.3.3,,vertical_menu_enabled,qode-title-hidden,qode_grid_1300,side_area_uncovered_from_content,qode-smooth-scroll-enabled,qode-child-theme-ver-1.0.0,qode-theme-ver-30.8.4,qode-theme-bridge,disabled_footer_bottom,qode_header_in_grid,qode-wpml-enabled,qode-portfolio-single-template-1,wpb-js-composer js-comp-ver-8.1,vc_responsive
jacobsen ingenierie cisbio curium CVC industrie pharmaceutique jacobsen ingenierie cisbio curium CVC industrie pharmaceutique
Category
Cleanrooms, Nuclear industry, Pharmaceuticals

HVAC ventilation equipment conformity and aging study

Client:

CURIUM Pharma is the world leader in the manufacture of radio-pharmaceutical products. BNI 29 at the CEA Saclay site produces radioactive substances.

Client needs:

Jacobsen Engineering carried out a conformity and aging study of the HVAC nuclear ventilation equipment in buildings 549 and 555.

Achievements:

Regulatory compliance studies of the General Operating Rules (RGE)
Safety Report (RS) regarding the applicable standards in nuclear ventilation: ISO 17873, ISO 10648-2, ISO 11933-4

Benchmarks:

Project owner: CURIUM
Project management: ECIA Group

Completion date: 09 to 11/2019